Contact
searchSearch
HMP Global

Peripheral Arterial Disease

Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest
Case Report
Hybrid Revascularization of a Thrombosed Bypass Graft with the Artix Thrombectomy System
11/01/2025
George DeKornfeld, MD
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in...
11/01/2025
Cath Lab Digest
Peripheral Intervention
Cagent Vascular Expands Serranator Product Line with Launch of 7.0 mm and 8.0 mm Sizes
10/07/2025
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon...
10/07/2025
Cath Lab Digest
Interview
A Literature Review of Atherectomy for Peripheral Interventions
09/19/2025
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
PAD Pulse Alliance
Peripheral Artery Disease (PAD) Awareness Month Urges Screening and Advocacy in National Effort to Prevent Amputations
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Bioresorbable Scaffolds
Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System Receives CE Mark, Pioneering a New Era in Peripheral Vascular Treatment
08/26/2025
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked...
08/26/2025
Cath Lab Digest
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Peripheral Imaging
Roadmap Imaging in the Endovascular Treatment of Complex Peripheral Vascular Disease
08/01/2025
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease...
08/01/2025
Cath Lab Digest
Peripheral Artery Disease
The Elusive Definitive Device for Amputation Reduction
06/04/2025
Mark C. Bates, MD, DSc(Hons), FACC, FSCAI
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization...
06/04/2025
Cath Lab Digest

Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest
Case Report
Hybrid Revascularization of a Thrombosed Bypass Graft with the Artix Thrombectomy System
11/01/2025
George DeKornfeld, MD
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in...
11/01/2025
Cath Lab Digest
Peripheral Intervention
Cagent Vascular Expands Serranator Product Line with Launch of 7.0 mm and 8.0 mm Sizes
10/07/2025
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon...
10/07/2025
Cath Lab Digest
Interview
A Literature Review of Atherectomy for Peripheral Interventions
09/19/2025
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
PAD Pulse Alliance
Peripheral Artery Disease (PAD) Awareness Month Urges Screening and Advocacy in National Effort to Prevent Amputations
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Bioresorbable Scaffolds
Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System Receives CE Mark, Pioneering a New Era in Peripheral Vascular Treatment
08/26/2025
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked...
08/26/2025
Cath Lab Digest
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Peripheral Imaging
Roadmap Imaging in the Endovascular Treatment of Complex Peripheral Vascular Disease
08/01/2025
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease...
08/01/2025
Cath Lab Digest
Peripheral Artery Disease
The Elusive Definitive Device for Amputation Reduction
06/04/2025
Mark C. Bates, MD, DSc(Hons), FACC, FSCAI
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization...
06/04/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

IVUS+OCT
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
05/08/2026
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and...
05/08/2026
Cath Lab Digest
Device Longevity
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
05/05/2026
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides...
05/05/2026
Cath Lab Digest
Stroke
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
05/05/2026
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s...
05/05/2026
Cath Lab Digest
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest
Mechanical Circulatory Support
Promising Data from US Pilot Study Shows Planned Impella 5.5 Use is Safe and Feasible in Non-Shock, High-Risk Cardiac Surgery Patients
05/05/2026
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson &...
05/05/2026
Cath Lab Digest
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
J. Dawn Abbott, MD, MSCAI
society news
SCAI Announces J. Dawn Abbott, MD, MSCAI, President for 2026–27
04/30/2026
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Optical Coherence Tomography
Abbott Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 AI-Powered Coronary Imaging Platform
04/28/2026
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first...
04/28/2026
Cath Lab Digest
CoraFlex and CoraForce microcatheters (Reflow Medical)
Microcatheters
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
04/24/2026
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary...
04/24/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use